Lenvat 4mg Capsule is primarily used for the treatment of thyroid cancer. It is specifically indicated for differentiated thyroid cancer (DTC) that is refractory to radioactive iodine treatment.
In more detail, Lenvat (lenvatinib) is a kinase inhibitor, a type of targeted cancer therapy. This medication works by blocking certain proteins (kinases) that promote cancer cell growth and the development of new blood vessels that feed the tumor. By inhibiting these kinases, lenvatinib can slow down or stop the growth of the cancerous cells.
Here's a breakdown:
- Primary Use: Treatment of differentiated thyroid cancer (DTC) that has progressed despite radioactive iodine therapy.
- Mechanism of Action: Lenvatinib inhibits several kinases, including vascular endothelial growth factor (VEGF) receptors, fibroblast growth factor (FGF) receptors, and others involved in tumor angiogenesis and growth.
- Important Considerations:
- The medication is usually taken once daily, with or without food. Following your doctor's instructions is crucial.
- Common side effects include diarrhea, fatigue, high blood pressure, decreased appetite, weight loss, nausea, stomatitis (mouth sores), and hand-foot syndrome (palmar-plantar erythrodysesthesia). It is essential to report any side effects to your doctor promptly.
- Due to potential side effects, regular monitoring of blood pressure, liver function, and kidney function is necessary during treatment.
It is vital to discuss Lenvat 4mg Capsule with your physician or healthcare provider to ascertain if it is the right treatment for your specific condition and to fully understand the potential risks and benefits. Do not self-medicate.
